These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12907539)

  • 1. Measurements of HIV viral loads from different levels of the respiratory tract.
    Wood KL; Chaiyarit P; Day RB; Wang Y; Schnizlein-Bick CT; Gregory RL; Twigg HL
    Chest; 2003 Aug; 124(2):536-42. PubMed ID: 12907539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study.
    Liuzzi G; Chirianni A; Clementi M; Bagnarelli P; Valenza A; Cataldo PT; Piazza M
    AIDS; 1996 Dec; 10(14):F51-6. PubMed ID: 8970677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection.
    Twigg HL; Soliman DM; Day RB; Knox KS; Anderson RJ; Wilkes DS; Schnizlein-Bick CT
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1439-44. PubMed ID: 10228108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.
    Twigg Iii HL; Weiden M; Valentine F; Schnizlein-Bick CT; Bassett R; Zheng L; Wheat J; Day RB; Rominger H; Collman RG; Fox L; Brizz B; Dragavon J; Coombs RW; Bucy RP;
    J Infect Dis; 2008 Jan; 197(1):109-16. PubMed ID: 18171293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia.
    Koziel H; Kim S; Reardon C; Li X; Garland R; Pinkston P; Kornfeld H
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2048-55. PubMed ID: 10588627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy.
    Ellis RJ; Childers ME; Cherner M; Lazzaretto D; Letendre S; Grant I;
    J Infect Dis; 2003 Dec; 188(12):1820-6. PubMed ID: 14673760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different resistance mutations can be detected simultaneously in the blood and the lung of HIV-1 infected individuals on antiretroviral therapy.
    White NC; Israel-Biet D; Coker RJ; Mitchell DM; Weber JN; Clarke JR
    J Med Virol; 2004 Mar; 72(3):352-7. PubMed ID: 14748057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood.
    García-Bujalance S; Ruiz G; De Guevara CL; Peña JM; Bates I; Vázquez JJ; Gutiérrez A
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):111-5. PubMed ID: 14735402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
    Celum CL; Buchbinder SP; Donnell D; Douglas JM; Mayer K; Koblin B; Marmor M; Bozeman S; Grant RM; Flores J; Sheppard HW
    J Infect Dis; 2001 Jan; 183(1):23-35. PubMed ID: 11106536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.
    Miller CS; Berger JR; Mootoor Y; Avdiushko SA; Zhu H; Kryscio RJ
    J Clin Microbiol; 2006 Jul; 44(7):2409-15. PubMed ID: 16825357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.
    Popper SJ; Sarr AD; Travers KU; Guèye-Ndiaye A; Mboup S; Essex ME; Kanki PJ
    J Infect Dis; 1999 Oct; 180(4):1116-21. PubMed ID: 10479138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors contributing to salivary human immunodeficiency virus type-1 levels measured by a Poisson distribution-based PCR method.
    Ikeno R; Yamada E; Yamazaki S; Ueda T; Nagata M; Takagi R; Kato S
    J Int Med Res; 2018 Mar; 46(3):996-1007. PubMed ID: 29119839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    J Infect Dis; 2004 Sep; 190(6):1076-83. PubMed ID: 15319856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.
    Gottlieb GS; Hawes SE; Agne HD; Stern JE; Critchlow CW; Kiviat NB; Sow PS
    AIDS; 2006 Apr; 20(6):895-900. PubMed ID: 16549974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India.
    Khopkar P; Sane S; Bichare S; Verma A; Kulkarni S
    J Clin Virol; 2013 Dec; 58(4):730-2. PubMed ID: 24238888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of quantitative polymerase chain reaction for equine herpesvirus-5 in blood, nasal secretions and bronchoalveolar lavage fluid for the laboratory diagnosis of equine multinodular pulmonary fibrosis.
    Pusterla N; Magdesian KG; Mapes SM; Zavodovskaya R; Kass PH
    Equine Vet J; 2017 Jan; 49(1):34-38. PubMed ID: 26639080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
    J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in HIV type 1 RNA plasma load profile of closely related cocirculating Ethiopian subtype C strains: C and C'.
    Ayele W; Mekonnen Y; Messele T; Mengistu Y; Tsegaye A; Bakker M; Berkhout B; Dorigo-Zetsma W; Wolday D; Goudsmit J; Coutinho R; de Baar M; Paxton WA; Pollakis G
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):805-13. PubMed ID: 20624072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva.
    Shugars DC; Slade GD; Patton LL; Fiscus SA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Apr; 89(4):432-40. PubMed ID: 10760726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.